Press Release
June 2, 2020
Amphastar Pharmaceuticals to Present at the Jefferies Virtual Healthcare Conference
More
May 7, 2020
Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended March 31, 2020
More
May 4, 2020
Amphastar Pharmaceuticals to Release First Quarter Earnings and Hold Conference Call on May 7th, 2020
More
April 27, 2020
Amphastar Pharmaceuticals, Inc. Receives FDA Approval for Epinephrine Injection, USP 30mg/30mL (1mg/mL) Multiple Dose Vial
More
April 13, 2020
Amphastar Pharmaceuticals, Inc. Announces Simplification of Management Structure
More
April 9, 2020
Amphastar Pharmaceuticals to Present at the 19th Annual Needham Virtual Healthcare Conference
More
March 12, 2020
Amphastar Pharmaceuticals Reports Financial Results for the Three Months and Full Year Ended December 31, 2019
More
March 5, 2020
Amphastar Pharmaceuticals to Release Fourth Quarter Earnings and Hold Conference Call on March 12th, 2020
More
February 27, 2020
Amphastar Pharmaceuticals Receives FDA Approval for Supplement to its Abbreviated New Drug Application for Sodium Bicarbonate Injection, USP 8.4%, 50mEq/50mL
More
January 28, 2020